Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

HELP

Helus Pharma Inc

May 13 • 04:00PM ET

5.18

+0.12 2.37 %

Healthcare • Biotechnology • Canada • Micro • NASD

Peers: URGN XERS CABA COGT OCGN

| Held by: PSIL

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.52	Insider Own	21.46%	Shs Outstand	49.89M	Perf Week	-6.50%
Market Cap	259.21M	Forward P/E	-	EPS next Y	-3.01	Insider Trans	0.00%	Shs Float	39.30M	Perf Month	-5.13%
Enterprise Value	64.08M	PEG	-	EPS next Q	-0.81	Inst Own	46.56%	Short Float	6.46%	Perf Quarter	-20.18%
Income	-122.31M	P/S	-	EPS this Y	2.64%	Inst Trans	22.86%	Short Ratio	2.13	Perf Half Y	-18.55%
Sales	0.00M	P/B	0.94	EPS next Y	24.55%	ROA	-52.45%	Short Interest	2.54M	Perf YTD	-36.67%
Book/sh	5.49	P/C	1.33	EPS next 5Y	15.32%	ROE	-55.47%	52W High	9.83 -47.30%	Perf Year	-21.40%
Cash/sh	3.90	P/FCF	-	EPS past 3/5Y	31.02% -232.48%	ROIC	-44.65%	52W Low	4.29 20.75%	Perf 3Y	-54.94%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.84% 7.97%	Perf 5Y	-91.48%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-18.26%	Oper. Margin	-	ATR (14)	0.38	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	13.78	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	47.55	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	13.78	EPS Q/Q	-166.25%	SMA20	-2.85%	Beta	0.79	Target Price	44.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-0.77%	Rel Volume	0.34	Prev Close	5.06
Employees	50	LT Debt/Eq	0.00	Earnings	Feb 16 BMO	SMA200	-18.45%	Avg Volume	1.19M	Price	5.18
IPO	Sep 13, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	-31.58% -	Trades		Volume	408,807	Change	2.37%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)